Target intelligence / Profile preview

Transmembrane protein 185A pseudogene 1 (TMEM185AP1)

Target: TMEM185AP1

Overview

Transmembrane protein 185A pseudogene 1 (TMEM185AP1) is a pseudogene, meaning it is a genomic DNA sequence similar to a gene but non-functional; it does not produce a functional protein product. It is not considered a receptor, enzyme, or any kind of classical drug target. There is no evidence of its involvement in therapeutic targeting, biological function, or disease association, and no drugs are known to interact with it[1].

Beyond the preview

Go deeper on Transmembrane protein 185A pseudogene 1 (TMEM185AP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 185A pseudogene 1 (TMEM185AP1).

Explore the full profile